Celyad SA is a biopharmaceutical company. The Company is engaged in stem cell-based therapies for the treatment of cardiovascular diseases. It is developing therapeutic therapies based on two distinct technology platforms in cardiology and oncology.
| Website: | www.celyad.com |
| Main Phone: | +32 10394100 |
| Address: | Rue Edouard Belin 2 |
| City / Town: | Mont-Saint-Guibert |
| Country: | BEL |
| Postal Code: | 1435 |
| Exchange: | NSD |
| CEO: | Christian Homsy |
| Employees: | 77 |
| Last Price 29.45 | Change $ 0.76 | Change % 2.65 | Tick N/A |
| Bid 29.41 | Bid Size 100.00 | Ask 30.14 | Ask Size 200.00 |
| Open 30.15 | High 30.15 | Low 29.45 | Prev Close 28.69 |
| Last Trade | Volume 3,001 | 52 Wk Hi 64.75 | 52 Wk Low 25.55 |
| Market Cap 335 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 11,373,844.00 | EPS (TTM) -7.03 | PE Ratio N/A | Exchange NSD |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 74 | 74 | 74 | 74 |
| Low Target Price Estimate | 49 | 74 | 74 | 49 |
| Mean Target Price Estimate | 61.5 | 74 | 74 | 61.5 |
| Standard Deviation | 17.68 | 0 | 0 | 17.68 |
| Date of Most Recent Estimate | 05/31/18 | 03/23/18 | 03/23/18 | 05/31/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 6-K | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 7 | 2018-05-23 |
| 6-K | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 58 | 2018-05-18 |
| 424B5 | Prospectus filed under Rule 424(b)(5) | 109 | 2018-05-18 |
| 6-K | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 8 | 2018-05-16 |
| 424B5 | Prospectus filed under Rule 424(b)(5) | 109 | 2018-05-16 |
| FWP | Free Writing Prospectus | 4 | 2018-05-16 |
| 6-K | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 37 | 2018-05-11 |
| 6-K | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 12 | 2018-05-03 |
| 20-F | Annual and transition report of foreign private issuers under sections 13 or 15(d) | 221 | 2018-04-06 |
| 6-K | Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act | 17 | 2018-03-23 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 3 | 1 | 1 | 1 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1 | 1 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
